As an effective cholesterol modulator, rosuvastatin has been proven to regulate HMGB1 in cholestatic liver injury[40] and myocardial ischemia [35,36] , but its function in IDD has not yet been fully explored. The gene discussed is HMGB1; the disease is myocardial ischemia.